Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study

NCT01391689 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT01391689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01391689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study
Lead sponsor
University of Arizona
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2011
Completion date
July 31, 2016
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iiia breast cancer